Tufts validates low-cost in-house urine culture for canine UTI screening

Version 2

A Tufts-led team is making the case that screening canine urinary tract infections in-house can be both clinically useful and financially realistic. Research from Tufts at Tech, a community veterinary clinic embedded in Worcester Technical High School and overseen by Cummings School faculty, found that a simple in-house urine culture plate performed well as a screening tool for bacteriuria in dogs with urinary signs, while costing far less than reference-laboratory culture and susceptibility testing. The study, published in the September 2024 issue of JAVMA, positions the approach as a practical way to expand access to care without abandoning antimicrobial stewardship. (vet.tufts.edu)

The work builds on a longstanding tension in small animal practice. Guidelines and expert recommendations continue to treat quantitative urine culture as the reference standard for diagnosing bacteriuria, with cystocentesis preferred when possible because voided samples carry contamination risk. At the same time, published research and expert commentary note that cost is one of the main reasons culture and susceptibility testing isn’t performed routinely, even when dogs present with lower urinary tract signs that can mimic infection. (academic.oup.com)

According to Tufts, the study evaluated 101 canine patients presenting with signs such as incontinence or hematuria over the course of a year. Investigators compared three in-house screening methods, including the in-house culture plate, against reference-laboratory culture and susceptibility testing. The in-house culture plate emerged as the least expensive option and the most accurate of the in-house methods for ruling out bacteriuria. Tufts reported a 99% negative predictive value for the in-house culture, and only 25 of the 101 cases were culture-positive by the reference standard. (vet.tufts.edu)

That low positivity rate is central to the clinical argument. If roughly three-quarters of dogs with urinary signs are culture-negative, an inexpensive in-house screen may help practices avoid unnecessary send-out testing in many cases while still identifying the smaller group that should move on to full susceptibility workups. Tufts clinicians framed the technique as a way to prioritize client resources and better distinguish bacterial infection from other causes of lower urinary tract signs, including stones and bladder cancer. (vet.tufts.edu)

Tufts has also moved beyond the paper itself. In June 2026, the school announced an open-access JAVMA technical tutorial video showing how to plate, incubate, and interpret canine urine cultures in clinic, including safety procedures, equipment, and examples of common organisms. The authors said the goal was to turn a validated technique into something general practices could realistically implement. They also emphasized that the method has been used for years in a teaching environment that includes veterinary students and high school veterinary assisting students, underscoring its operational simplicity. (vet.tufts.edu)

The broader industry perspective supports the stewardship angle, with some caution. ISCAID guidance discourages treatment of subclinical bacteriuria in most animals and stresses that testing should be guided by clinical signs and intended treatment decisions, not by a reflex to culture every abnormal urine sample. Meanwhile, American College of Veterinary Microbiologists recommendations emphasize careful interpretation of colony counts and collection method, especially when cystocentesis isn’t feasible. In other words, an in-house culture can be useful, but it doesn’t eliminate the need for sound case selection, proper sample handling, and confirmatory testing when growth is detected or the case is complicated. (amrvetcollective.com)

Why it matters: For veterinary professionals, this is less about replacing the lab than about creating a triage layer that fits real-world practice economics. A high-performing negative screen could help clinics reduce unnecessary antibiotic exposure, shorten decision time, and make evidence-based UTI workups more available to pet parents who might otherwise decline testing on cost grounds. That matters in community practice, urgent care, and shelters, where urinary complaints are common and empiric prescribing pressure can be high. The approach also aligns with a larger shift toward diagnostic stewardship, using lower-cost tools to decide when more intensive testing is truly warranted. (vet.tufts.edu)

What to watch: The next question is adoption. Tufts has already published implementation guidance through JAVMA, and the clinic says it is continuing related access-to-care and antimicrobial stewardship research in canine UTIs. What will matter now is whether private practices can reproduce the workflow, maintain quality control, and define clear protocols for when a negative in-house screen is enough, and when a positive or equivocal result should trigger full laboratory culture and susceptibility testing. (vet.tufts.edu)